BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17652274)

  • 1. Breast cancer trends: a marriage between clinical trial evidence and epidemiology.
    Berry DA; Ravdin PM
    J Natl Cancer Inst; 2007 Aug; 99(15):1139-41. PubMed ID: 17652274
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reviews of hormone replacement therapy evidence support findings in recently halted trial.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Sep; 13(17):7-9. PubMed ID: 12572547
    [No Abstract]   [Full Text] [Related]  

  • 5. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogen.
    Shapiro S; Farmer RD; Mueck AO; Seaman H; Stevenson JC
    J Fam Plann Reprod Health Care; 2011 Oct; 37(4):225-30. PubMed ID: 21642263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical?
    Shapiro S
    Climacteric; 2015 Jun; 18(3):333-5. PubMed ID: 25651904
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR
    Cancer; 2003 Oct; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract]   [Full Text] [Related]  

  • 10. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening and detection of breast cancer and prostate cancer.
    Saloustros E; Mavroudis D
    JAMA; 2010 Mar; 303(11):1032; author reply 1033-4. PubMed ID: 20233817
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Chu DZ
    J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Helmond FA
    Lancet; 2003 Oct; 362(9392):1330; author reply 1330-1. PubMed ID: 14575988
    [No Abstract]   [Full Text] [Related]  

  • 15. Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries.
    Zbuk K; Anand SS
    J Epidemiol Community Health; 2012 Jan; 66(1):1-7. PubMed ID: 21875869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HRT, HERS, NIH, WHI: alphabet soup?
    Legato MJ
    J Gend Specif Med; 2002; 5(6):10-3. PubMed ID: 12503220
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Byers T; Trujillo S; Hines L
    J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X; Seeger H; Mueck AO
    Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.